$19.17
-0.56-2.84%
At close: Dec 16, 4:00 PM EST
$19.22
0.050.26%
After Hours: 6:19 PM EST
Comments
Loading...
ADMA Biologics Stock Guidance | NASDAQ:ADMA | Benzinga
ADMA Biologics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/05/2025 | ADMA | ADMA Biologics | FY | 2026 | — | — | — | $630.00M | — | $639.31M | Get Alert |
| 11/05/2025 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $510.00M | — | $506.45M | Get Alert |
| 08/06/2025 | ADMA | ADMA Biologics | FY | 2026 | — | — | — | $500.00M | $625.00M | $638.85M | Get Alert |
| 08/06/2025 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $500.00M | $625.00M | $505.82M | Get Alert |
| 05/07/2025 | ADMA | ADMA Biologics | FY | 2026 | — | — | — | $625.00M | — | $600.68M | Get Alert |
| 05/07/2025 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $500.00M | — | $496.37M | Get Alert |
| 03/03/2025 | ADMA | ADMA Biologics | FY | 2026 | — | — | — | $605.00M | — | — | Get Alert |
| 03/03/2025 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $490.00M | — | $482.41M | Get Alert |
| 01/13/2025 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $485.00M | — | $486.79M | Get Alert |
| 01/13/2025 | ADMA | ADMA Biologics | FY | 2026 | — | — | — | $600.00M | — | — | Get Alert |
| 01/13/2025 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $417.00M | $425.00M | $423.19M | Get Alert |
| 11/07/2024 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $465.00M | — | $459.22M | Get Alert |
| 11/07/2024 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $415.00M | — | $406.09M | Get Alert |
| 08/08/2024 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $400.00M | — | $357.50M | Get Alert |
| 08/08/2024 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $445.00M | — | $414.48M | Get Alert |
| 05/09/2024 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $355.00M | — | $333.87M | Get Alert |
| 05/09/2024 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $410.00M | — | $389.87M | Get Alert |
| 02/28/2024 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $330.00M | — | $315.30M | Get Alert |
| 02/28/2024 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $380.00M | — | — | Get Alert |
| 01/08/2024 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $256.00M | $258.00M | $252.79M | Get Alert |
| 01/08/2024 | ADMA | ADMA Biologics | Q4 | 2023 | — | — | — | $72.00M | $74.00M | $68.49M | Get Alert |
| 11/08/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $335.00M | — | — | Get Alert |
| 11/08/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $290.00M | — | $278.40M | Get Alert |
| 11/08/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $250.00M | — | $243.06M | Get Alert |
| 08/09/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $275.00M | — | $262.00M | Get Alert |
| 08/09/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $240.00M | — | $226.03M | Get Alert |
| 08/09/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $325.00M | — | — | Get Alert |
| 05/10/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $220.00M | — | $212.36M | Get Alert |
| 05/10/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | $258.84M | Get Alert |
| 05/10/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | — | — | Get Alert |
| 03/23/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | — | — | Get Alert |
| 03/23/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | — | Get Alert |
| 03/23/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $210.00M | — | $202.75M | Get Alert |
| 01/17/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $210.00M | — | $197.45M | Get Alert |
| 01/17/2023 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $153.00M | $154.00M | $148.95M | Get Alert |
| 01/17/2023 | ADMA | ADMA Biologics | Q4 | 2022 | — | — | — | $49.00M | $50.00M | $43.75M | Get Alert |
| 12/06/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $152.00M | $154.00M | $145.86M | Get Alert |
| 12/06/2022 | ADMA | ADMA Biologics | Q4 | 2022 | — | — | — | $48.00M | $50.00M | $40.66M | Get Alert |
| 11/09/2022 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | — | Get Alert |
| 11/09/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $145.00M | $145.00M | $134.39M | Get Alert |
| 08/10/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $130.00M | — | $131.92M | Get Alert |
| 08/10/2022 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | — | Get Alert |
| 08/10/2022 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | — | — | Get Alert |
| 05/11/2022 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | $300.00M | — | Get Alert |
| 05/11/2022 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | $250.00M | — | Get Alert |
| 05/11/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $130.00M | — | $128.50M | Get Alert |
| 03/24/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $125.00M | — | $112.77M | Get Alert |
| 01/19/2022 | ADMA | ADMA Biologics | Q4 | 2021 | — | — | — | $26.00M | $26.00M | $21.76M | Get Alert |
| 01/19/2022 | ADMA | ADMA Biologics | FY | 2021 | — | — | — | $81.00M | $81.00M | $76.27M | Get Alert |
FAQ
Q
What is the most recent guidance for ADMA Biologics (ADMA)?
A
There have been no specific sales or earnings guidance reported for ADMA Biologics in recent months.
Browse guidance and forecast on all stocks.
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved